Art

J-GLOBAL ID：201802230101492396   Reference number：18A1765749

Additional chromosomal abnormalities at diagnosis and their impact on treatment response in CML

診断での付加的染色体異常とCMLにおける治療応答に対するそれらの影響

Author (16)： ISHIKAWA Maho (Saitama Medical Univ. International Medical Center, Saitama, JPN) ,  IRIYAMA Noriyoshi (Nihon Univ., Tokyo, JPN) ,  TOKUHIRA Michihide (Saitama Medical Univ., Saitama, JPN) ,  TAKAKU Tomoiku (Juntendo Univ. School of Medicine, Tokyo, JPN) ,  SATO Eriko (Juntendo Univ. Nerima Hospital, Tokyo, JPN) ,  SUGIMOTO Keiji (Juntendo Univ. Urayasu Hospital, Urayasu, JPN) ,  NAKAZATO Tomonori (Yokohama Municipal Citizen’s Hospital, Yokohama, JPN) ,  IWANAGA Eisaku (Kumamoto Univ. Hospital, Kumamoto, JPN) ,  FUJITA Hiroyuki (Saiseikai Yokohama Nanbu Hospital, Yokohama, JPN) ,  KIMURA Yuta (Saitama Medical Univ., Saitama, JPN) ,  FUJIOKA Isao (Juntendo Univ. School of Medicine, Tokyo, JPN) ,  KOMATSU Norio (Juntendo Univ. School of Medicine, Tokyo, JPN) ,  ASOU Norio (Saitama Medical Univ. International Medical Center, Saitama, JPN) ,  KIZAKI Masahiro (Saitama Medical Univ., Saitama, JPN) ,  HATTA Yoshihiro (Nihon Univ., Tokyo, JPN) ,  KAWAGUCHI Tatsuya (Kumamoto Health Sci. Univ., Kumamoto, JPN)
Material： 臨床血液  (Japanese Journal of Clinical Hematology)
Volume： 59  Issue： 9  Page： 1561  Publication year： Sep. 30, 2018 
JST Material Number： Z0688A  ISSN： 0485-1439  Document type： Article
Article type： 会議録記事  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *chronic myeloid leukemia ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1765749&from=J-GLOBAL&jstjournalNo=Z0688A") }}

JST classification (5)： Blood cell tumors(=neoplasms)  (GK04000M) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of enzyme preparations and inhibitor preparations  (GW21020H) ,  Clinical application of other drugs  (GW23020V) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (3)： Imatinib ,  Nilotinib ,  Dasatinib

Terms in the title (4)： 診断 ,  染色体異常 ,  CML ,  治療応答